NoV VP1

NoV VP1 Product List

  • Product Category

    Antibody (1)

  • Product Status

    Launched (1)

  • Species

    Mouse (1)

  • Tag

    - (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
NO1-MY2188
Mouse
HEK293
Monoclonal Anti-Human NoV VP1 Antibody, Mouse IgG1 (5B4) (MALS verified)
Total: 1
  • 1

NoV VP1 Background

Noroviruses are icosahedral viruses in the family Caliciviridae, with a single-stranded, positive-sense RNA genome. Noroviruses are genetically diverse and can infect a wide variety of hosts. Norovirus is a leading cause of acute gastroenteritis (AGE) globally. They are divided into 10 genogroups (GI to GX) based on VP1 amino acid sequence. Each genogroup is subdivided into genotypes based on capsid amino acid sequence, with 49 genotypes currently described. Noroviruses can also be classified based on their RdRp (“polymerase”) sequence, with at least 60 P-types currently circulating.

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Vindesine sulfateCompound-112531ApprovedEli Lilly And CompanyEldisineUnited KingdomLymphoma; Melanoma; Breast Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung; LeukemiaEli Lilly And Company1979-01-01Leukemia; Esophageal Neoplasms; Small Cell Lung Carcinoma; Breast Neoplasms; Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma
Details
  • Product List
  • Marketed Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland